BioSpace News Archive

Biosimilars Canada is pleased to announce the unanimous re-election of Mr. Michel Robidoux, President and General Manager of Sandoz Canada, as Chair of the Biosimilars Canada Board.

With National Colorectal Cancer Awareness Month now entering its 21st year, Taiho Oncology, Inc., announced today it has joined with leading patient advocacy organizations to help raise awareness of the unique challenges faced by patients living with colorectal cancer and provide educational resources to support their journey.

Today, at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting held virtually, BioSkryb, Inc., a developer of genomic amplification technologies, announced the winners of a research grant program sponsored by the company.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jordan Pinsker, MD, to Vice President and Medical Director, effective April 26, 2021.

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for the Spatial Molecular Imager.

MBF Bioscience (“MBF”), a leading provider of bioscience image analysis tools, announced today that it has completed the acquisition of Vidrio Technologies (“Vidrio”). Terms of the transaction were not disclosed.

The Canadian Cancer Society and Ludovick Bourgeois will take advantage of the month of March, Colorectal Cancer Awareness Month, to educate Quebecers 50 to 74 years old about a test that can detect colon cancer early on and encourage them to speak to their doctori about taking the test every two years, either face-to-face or by virtual consultation during the pandemic.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), allowing the company to market its new QuickVue® At-Home COVID-19 Test

Children’s National Hospital and Takeda Pharmaceutical Company Limited announced the creation of the Rare Disease Clinical Activity Protocols program, which will establish a networked system for the development, dissemination and curation of protocols to help standardize the process of diagnosis and care for patients with rare diseases.

Vitacore Industries Inc. has received Health Canada Authorization for its CAN99 respirator on February 19, 2021, becoming the first Canadian made N99 equivalent single-use respirator.